Kristin Lehmkemper1,2, Samuel O Kyeremateng3, Matthias Degenhardt1, Gabriele Sadowski4. 1. Global Pharmaceutical R&D, AbbVie Deutschland GmbH & Co. KG, Knollstraße, D-67061, Ludwigshafen am Rhein, Germany. 2. Department of Biochemical and Chemical Engineering, Laboratory of Thermodynamics, TU Dortmund, Emil-Figge-Str. 70, D-44227, Dortmund, Germany. 3. Global Pharmaceutical R&D, AbbVie Deutschland GmbH & Co. KG, Knollstraße, D-67061, Ludwigshafen am Rhein, Germany. samuel.kyeremateng@abbvie.com. 4. Department of Biochemical and Chemical Engineering, Laboratory of Thermodynamics, TU Dortmund, Emil-Figge-Str. 70, D-44227, Dortmund, Germany. gabriele.sadowski@tu-dortmund.de.
Abstract
PURPOSE: The oral bioavailability of poorly water-soluble active pharmaceutical ingredients (APIs) can be improved by the preparation of amorphous solid dispersions (ASDs) where the API is dissolved in polymeric excipients. Desired properties of such ASDs like storage stability, dissolution behavior, and processability can be optimized by additional excipients. In this work, the influence of so-called low-molecular-weight excipients (LMWEs) on the phase behavior of ASDs was investigated. METHOD: Binary ASDs of an amorphous API, naproxen (NAP) or acetaminophen (APAP), embedded in poly-(vinylpyrrolidone-co-vinyl acetate) (PVPVA64) were chosen as reference systems. Polyethylene glycol 1500 (PEG1500), D-α-tocopherol polyethylene glycol 1000 succinate (TPGS1000), propylene glycol monocaprylate type II (Capryol™ 90), and propylene glycol monolaurate type I (Lauroglycol™ FCC) were used as LMWEs. The API solubility in the excipients and the glass-transition temperature of the ASDs were modeled using the Perturbed-Chain Statistical Associating Fluid Theory (PC-SAFT) and the Kwei equation, respectively, and compared to corresponding experimental data. RESULTS: The API solubility curves in ternary systems with 90/10 wt%/wt% PVPVA64/LMWE ratios were very close to those in pure PVPVA64. However, the glass-transition temperatures of API/PVPVA64/LMWE ASDs were much lower than those of API/PVPVA64 ASDs. These effects were determined experimentally and agreed with the predictions using the PC-SAFT and Kwei models. CONCLUSION: The impact of the LMWEs on the thermodynamic stability of the ASDs is quite small while the kinetic stability is significantly decreased even by small LMWE amounts. PC-SAFT and the Kwei equation are suitable tools for predicting the influence of LMWEs on the ASD phase behavior.
PURPOSE: The oral bioavailability of poorly water-soluble active pharmaceutical ingredients (APIs) can be improved by the preparation of amorphous solid dispersions (ASDs) where the API is dissolved in polymeric excipients. Desired properties of such ASDs like storage stability, dissolution behavior, and processability can be optimized by additional excipients. In this work, the influence of so-called low-molecular-weight excipients (LMWEs) on the phase behavior of ASDs was investigated. METHOD: Binary ASDs of an amorphous API, naproxen (NAP) or acetaminophen (APAP), embedded in poly-(vinylpyrrolidone-co-vinyl acetate) (PVPVA64) were chosen as reference systems. Polyethylene glycol 1500 (PEG1500), D-α-tocopherol polyethylene glycol 1000 succinate (TPGS1000), propylene glycol monocaprylate type II (Capryol™ 90), and propylene glycol monolaurate type I (Lauroglycol™ FCC) were used as LMWEs. The API solubility in the excipients and the glass-transition temperature of the ASDs were modeled using the Perturbed-Chain Statistical Associating Fluid Theory (PC-SAFT) and the Kwei equation, respectively, and compared to corresponding experimental data. RESULTS: The API solubility curves in ternary systems with 90/10 wt%/wt% PVPVA64/LMWE ratios were very close to those in pure PVPVA64. However, the glass-transition temperatures of API/PVPVA64/LMWE ASDs were much lower than those of API/PVPVA64 ASDs. These effects were determined experimentally and agreed with the predictions using the PC-SAFT and Kwei models. CONCLUSION: The impact of the LMWEs on the thermodynamic stability of the ASDs is quite small while the kinetic stability is significantly decreased even by small LMWE amounts. PC-SAFT and the Kwei equation are suitable tools for predicting the influence of LMWEs on the ASD phase behavior.
Entities:
Keywords:
amorphous solid dispersion, PC-SAFT, phase behavior, surfactants, thermodynamic model
Authors: Frank Theil; Sankaran Anantharaman; Samuel O Kyeremateng; Holger van Lishaut; Sebastian H Dreis-Kühne; Jörg Rosenberg; Markus Mägerlein; Gerd H Woehrle Journal: Mol Pharm Date: 2016-11-30 Impact factor: 4.939
Authors: Sandrien Janssens; Sophie Nagels; Hector Novoa de Armas; Ward D'Autry; Ann Van Schepdael; Guy Van den Mooter Journal: Eur J Pharm Biopharm Date: 2007-11-19 Impact factor: 5.571
Authors: Evert Fuenmayor; Martin Forde; Andrew V Healy; Declan M Devine; John G Lyons; Christopher McConville; Ian Major Journal: Pharmaceutics Date: 2018-04-02 Impact factor: 6.321
Authors: Justyna Knapik-Kowalczuk; Daniel Kramarczyk; Krzysztof Chmiel; Jana Romanova; Kohsaku Kawakami; Marian Paluch Journal: Pharmaceutics Date: 2020-04-22 Impact factor: 6.321